Wang et al. showed that the treatment or transfection of HCC cells with exosomal miR-125a and exosomal miR-125b from tumor-associated macrophages (TAMs) inhibited tumor cell proliferation and stem cell characteristics, which was associated with exosomal miR-125a/b targeting CD90 [71]. This evidence concerns the gene THY1 and neoplasm.